Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides

Fig. (1) Virus-specific serum and local immune responses in mice after primary vaccination and revaccination with 10⁶ EID₅₀ (H7N3) LAIV or combined LAIV and GBS vaccine (n=8). (a) HI antibodies were detected against A (H7N3) vaccine virus and A/PR8/34 influenza virus. (b) The whole purified A(H7N3) vaccine virus was used for ELISA assay. Reciprocal antibody titers were expressed as log₂ (HI) or as log₁₀ (ELISA) and presented as mean±SEM, (*) - p=0.02.